INTERNATIONAL PATENT: APOGEE THERAPEUTICS, INC. FILES APPLICATION FOR "DOSAGE AND ADMINISTRATION OF AN ANTI-OX40L ANTIBODY"

GENEVA, Dec. 17 -- APOGEE THERAPEUTICS, INC. (221 Crescent StreetWaltham, MA 02453) filed a patent application (PCT/US2025/032460) for "DOSAGE AND ADMINISTRATION OF AN ANTI-OX40L ANTIBODY" on Jun 05, 2025. With publication no. WO/2025/255353, the details related to the patent application was published on Dec 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DILLINGER, Lukas (Sandleitengasse 17/1/51160 Vienna), DAMBKOWSKI, Carl, Linden (c/o Apogee Therapeutics, Inc.221 Crescent StreetWaltham, MA 02453), WINTER, Erica (c/o Apogee Therapeutics, Inc.221 Crescent StreetWaltham, MA 02453), NOGRA...